Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

HPV-unrelated Head and Neck Squamous Cell Carcinoma

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Sanford Worthington Medical Center, Worthington, Minnesota, United States
Contact: Study coordinator (Steven Powell, M.D.) · 507-372-2941
Contact: Principal Investigator (Steven Powell, M.D.)
Saint Luke's Hospital, Kansas City, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Douglas Adkins, M.D.) · dadkins@wustl.edu · 314-747-8475
Contact: Principal Investigator (Douglas Adkins, M.D.)
Peter Oppelt, M.D. (Sub-investigator)
Esther Lu, Ph.D. (Sub-investigator)
Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States
Contact: Study coordinator (Daniel Almquist, M.D.) · 701-234-6161
Contact: Principal Investigator (Daniel Almquist, M.D.)
Sanford Medical Center, Sioux Falls, South Dakota, United States
Contact: Study coordinator (Steven Powell, M.D.) · 605-328-8000
Contact: Principal Investigator (Steven Powell, M.D.)

מובילי המחקר

Douglas Adkins, M.D.
Principal Investigator
Washington University School of Medicine